Bromelain has Antioxidant Effect on Methotrexate Hepatotoxicity and Nephrotoxicity

Yıl 2022, , 37 - 42, 30.04.2022

Ali Gürel , Kürşat Kaya

https://doi.org/10.52976/vansaglik.982411

Cited By: 2

Öz

Objective: The goal of this study was to look into whether bromelain (BRM) could protect against methotrexate (MTX)-induced kidney and liver damage.
Material and Method: The rats were divided into four groups (n=7); the control group was given distilled water by gavage for 14 days and intraperitoneal (i.p.) physiological saline (%0.9 NaCI) on the third day; the BRM group was given 200 mg/kg BRM by gavage for 14 days and i.p. physiological saline (%0.9 NaCI) on third day; the MTX group was given distilled water by gavage for 14 days and i.p. single dose of 20 mg/kg MTX on the third day; the MTX+BRM group was given 200 mg/kg BRM by gavage for 14 days and i.p. single dose of 20 mg/kg MTX on the third day. Rats were decapitated at the end of the experiment, kidney and liver tissues were kept at -80°C, and biochemical analyzes were performed on the supernatants obtained from tissue homo-gentates.
Results: With the administration of MTX, oxidation indicator thiobarbituric acid reactive substance (TBARS) levels increased in comparison with the control group; antioxidants- glutathione peroxidase (GPx), glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) activities were decreased compared to the control group. Co-administration of BRM with MTX resulted in reduction in TBARS level and increase in GSH, CAT, SOD, and GPx activities.
Conclusion: In this study, it was determined that MTX caused oxidative damage in kidney and liver tissues and BRM prevented this damage.

Anahtar Kelimeler

Methotrexate, Oxidative damage, Kidney, Liver, Bromelain

Bromelain Metotreksat Hepatotoksisitesi ve Nefrotoksisitesi Üzerine Antioksidan Etkilidir

Öz

Amaç: Bu çalışmada bromelainin (BRM) metotreksat (MTX) kaynaklı böbrek ve karaciğer hasarına karşı potansiyel koruyucu etkilerinin araştırılması amaçlandı.
Materyal ve Metot: Dört gruba ayrılan sıçanlarda (n=7); kontrol grubuna 14 gün gavaj yoluyla distile su ve üçüncü gün intraperitoneal (i.p.) fizyolojik salin (%0.9 NaCI) verildi; BRM grubuna 14 gün boyunca gavaj yol-uyla 200 mg/kg BRM ve üçüncü gün i.p fizyolojik salin (%0.9 NaCI); MTX grubuna 14 gün boyunca gavaj yolu-yla distile su ve üçüncü günde i.p. tek doz 20 mg/kg MTX; BRM+MTX grubuna 14 gün boyunca gavaj yoluyla 200 mg/kg BRM ve üçüncü günde i.p. tek doz 20 mg/kg MTX uygulandı. Deney sonunda sıçanlar dekapite edildi, böbrek ve karaciğer dokuları -80 °C'de muhafaza edilerek, doku homojentlarından elde edilen superna-tantlarda biyokimyasal analizler gerçekleştirildi.
Bulgular: MTX uygulaması ile oksidasyon belirteci tiyobarbitürik asit reaktif madde (TBARS) seviyeleri kontrol grubuna kıyasla arttı; antioksidanlar süperoksit dismutaz (SOD), glutatyon (GSH), glutatyon peroksidaz (GPx) ve katalaz (CAT) aktiviteleri kontrol grubuna göre azaldı. BRM'nin MTX ile birlikte uygulanması, TBARS se-viyesinde azalmaya ve GSH, CAT, SOD ve GPx aktivitelerinde artışa neden oldu.
Sonuç: Bu çalışmada MTX'in böbrek ve karaciğer dokularında oksidatif hasara neden olduğu ve BRM'nin bu hasarı önlediği belirlenmiştir.

Anahtar Kelimeler

Metotreksat, Oksidatif hasar, Böbrek, Karaciğer, Bromelain.

Kaynakça

• 1. Hafez HM, Ibrahim MA, Ibrahim SA, Amin EF, Goma W, Abdelrahman AM. Potential protective effect of etanercept and aminoguanidine in methotrexate-induced hepatotoxicity and nephrotoxicity in rats. Eur J Pharmacol 2015;768:1–12.
• 2. Bernsen EC, Hagleitner MM, Kouwenberg TW, Hanff LM. Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology. Front Pharmacol. 2020;11:1–19.
• 3. El Demerdash FM, Baghdadi HH, Ghanem NF, Mhanna ABA. Nephroprotective role of bromelain against oxidative injury induced by aluminium in rats. Environ Toxicol Pharmacol 2020;80:103509.
• 4. Pavan R, Jain S, Shraddha, Kumar A. Properties and therapeutic application of bromelain: a review. Biotechnol Res Int 2012;2012:1-6.
• 5. White RR, Crawley FE, Vellini M, Rovati LA. Bioavailability of 125I bromelain after oral administration to rats. Biopharm Drug Dispos 1988;9:397-403.
• 6. Castell JV, Friedrich G, Kuhn CS, Poppe GE. Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intake. Am J Physiol 1997;273:139-146.
• 7. Ataide JA, De Carvalho NM, Rebelo MDA, Chaud MV, Grotto D, Gerenutti M. Bacterial nanocellulose loaded with bromelain: assessment of antimicrobial, antioxidant and physical-chemical properties. Sci Rep 2017;7:2-10.
• 8. Jebur AB, El Demerdash FM, Kang W. Bromelain from Ananas comosus stem attenuates oxidative toxicity and testicular dysfunction caused by aluminum in rats. J Trace Elem Med Biol 2020;62:126631.
• 9. Yagi K. Simple assay for the level of total lipid peroxides in serum or plasma. Methods Mol Biol. 1998;108:101–106.
• 10. Ighodaro OM, Akinloye OA. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alexandria J Med 2018;54(4):287–293.
• 11. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34(3):497–500.
• 12. Aebi H. Catalase. Methods Enzym Anal. 1974;673–684.
• 13. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70(1):158–169.
• 14. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem. 1968;25(C):192–205.
• 15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. The folin by oliver. Readings. 1951;193(1):265–275.
• 16. Wang W, Zhou H, Liu L. Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review. Eur J Med Chem 2018;158:502–516.
• 17. Campbell JM, Bateman E, Peters MDJ, Bowen JM, Keefe DM, Stephenson MD. Fluoropyrimidine and platinum toxicity pharmacogenetics: An umbrella review of systematic reviews and meta-analyses. Pharmacogenomics 2016;17(4):435–451.
• 18. Yalçın A, Gürel A. Theraupeutic potency of benfotiamine against methotrexate-induced kidney injury and irisin immunoreactivity. Journal of Ankara Health Sciences (JAHS) 2020, 9(2): 244-253.
• 19. Vardi N, Parlakpinar H, Cetin A, Erdogan A, Cetin OI. 2010. Protective effect of β-carotene on methotrexate– induced oxidative liver damage. Toxicol Pathol. 38(4):592-597.
• 20. Agarwal S, Chaudhary B, Bist R. Bacoside a and bromelain relieve dichlorvos induced changes in oxidative responses in mice serum. Chem Biol Interact 2016;254:173-178.